Concepedia

BCR‐ABL positive chronic myeloid leukemia with concurrent <i>JAK2</i><sup><i>V617F</i></sup> positive myelodysplastic syndrome/myeloproliferative neoplasm (RARS‐T)

Stefan Gattenlöhner, Hans‐Ulrich Völker, Benjamin Etschmann, Hermann Einsele, Hans–Konrad Müller–Hermelink

American Journal of Hematology · 2008 · 17 citations · 2 references

Open access

Concepts

MedicineGeneticsHematologyHematologic OncologyHematopathologyMolecular OncologyHematologic MalignanciesHematologic Malignancy TherapyHematopoietic NeoplasmsMyelodysplastic SyndromesMyeloproliferative NeoplasmsChronic LeukemiasJak2 V617f MutationMyeloproliferative Neoplasm Therapy

References

2

Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders

Róbert Královics, Soon-Siong Teo, Sai Li et al. · Blood · 2006 · 280 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis

Annette Schmitt‐Graeff, Swee‐Sen Teo, Manfred Olschewski et al. · Haematologica · 2007 · 119 citations · Full text

Medicine, Genetics, Hematology +16